288 results
8-K
EX-99.1
ONCT
Oncternal Therapeutics Inc
7 Mar 24
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
4:10pm
initial response results and we believe that the protocol amendments will further ensure patient safety as we investigate the optimal dose of ONCT
8-K
EX-10.1
ONCT
Oncternal Therapeutics Inc
23 Jan 24
Entry into a Material Definitive Agreement
4:05pm
mean a pivotal human clinical trial in any country the results of which could be used to establish safety and efficacy of Licensed Product as a basis
8-K
8bvt79n
12 Dec 22
Other Events
6:03am
8-K
kq3zesy0z 98abxrmr
26 May 22
Other Events
5:25pm
8-K
EX-99.1
vphuu5kez
10 Mar 22
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2021 Financial Results
4:15pm
8-K
EX-1.1
k0afo5rzx3hu 7jrl
17 Dec 21
Entry into a Material Definitive Agreement
5:17pm
8-K
ywll9rp ygvgk0
13 Dec 21
Other Events
4:00pm
8-K
EX-99.1
xiiqr7q ayq
5 Aug 21
Oncternal Provides Business Update and Announces Second Quarter 2021 Financial Results
4:00pm
8-K
EX-1.1
hpdz81 a6ykwie72uq
28 May 21
Entry into a Material Definitive Agreement
5:03pm
8-K
vk7mqhzs ufzg0h5wt
20 May 21
Other Events
6:02am